Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIA Prostate Cancer”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Very early researchStudy completedNCT04976257
What this trial is testing

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaStage IIC Prostate Cancer AJCC v8+7 more
Ryan Kohlbrenner, MD 5
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT03177460
What this trial is testing

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 33
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Not applicableEnded earlyNCT04927559
What this trial is testing

Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+27 more
University of Southern California 35
Early research (Phase 1)Active Not RecruitingNCT01480154
What this trial is testing

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmStage III Cutaneous Melanoma AJCC v7Stage III Prostate Cancer AJCC v7+7 more
National Cancer Institute (NCI) 62
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT03279250
What this trial is testing

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 86
Not applicableActive Not RecruitingNCT04189770
What this trial is testing

Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners

Who this might be right for
Cancer SurvivorPartnerSpouse+9 more
M.D. Anderson Cancer Center 200
Not applicableLooking for participantsNCT04725903
What this trial is testing

Proton Radiation Therapy for the Treatment of Patients with High Risk Prostate Cancer

Who this might be right for
Stage III Prostate Cancer AJCC V8Stage IIIA Prostate Cancer AJCC V8Stage IIIB Prostate Cancer AJCC V8+1 more
Emory University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06067269
What this trial is testing

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

Who this might be right for
Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 95
Not applicableActive Not RecruitingNCT04985565
What this trial is testing

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 12
Not applicableActive Not RecruitingNCT04215029
What this trial is testing

Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans

Who this might be right for
Cancer SurvivorPartnerSpouse+9 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00074022
What this trial is testing

GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Prostate CancerStage III Prostate Cancer+5 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT03570827
What this trial is testing

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+3 more
Mayo Clinic 52
Not applicableStudy completedNCT03112668
What this trial is testing

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

Who this might be right for
Malignant Female Reproductive System NeoplasmMalignant Hepatobiliary NeoplasmPartner+36 more
Rutgers, The State University of New Jersey 14
Load More Results